Technologies Found (140)
Array ( [cache_time] => 0 [counts_time] => 0 [query_time] => [category_counts_time] => 0 [total_time] => 0 )
Technology NameBriefcaseLead Researcher
 Background Glioblastoma multiforme (GBM) is a common, very aggressive brain cancer with a dismal prognosis, affecting young and middle-age adults with no effective treatment. Former efforts to diagnose glioblastoma tumors and tailor personal ...
More
Hellman Asaf
Background Peripheral Arterial Disease (PAD) is the narrowing of peripheral arteries. By age 60 approximately 15% of the China population will have PAD. The problem commonly affects the lower limbs. Lower limb PAD is often diagnosed in late ...
More
Nahmias Yaakov
Our Innovation We developed an efficient strategy to induce the formation of the endonuclease YqcG within bacterial cells. Within minutes following induction, 99.98% of the cells lose their genetic information and become DNA-less cells ...
More
Ben-Yehuda Sigal
  Additional information will be provided upon request
More
Benita Simon
  Additional information will be provided upon request
More
Domb Abraham
  Additional information will be provided upon request
More
Domb Abraham
  Additional information will be provided upon request
More
Shoseyov Oded
  Additional information will be provided upon request
More
Domb Abraham
Background With continuous increase in the elderly population, many age-related health problems have become a major healthcare issue. Attenuating deleterious age-related processes taking place in multiple organs is highly desirable. Our ...
More
Keshet Eli
Background Fatty liver disease - Non alcoholic fatty liver disease (NAFLD) is  a continuum of diseases that include simple steatosis and non-alcoholic steatohepatitis (NASH) ultimately leading to cirrhosis, hepatocellular carcinoma (HCC) and/or ...
More
Tirosh Oren
  Categories Superactive High Afinity Leptin antagonist, mutein, multiple sclerosis, inflammatory bowel syndrome, rheumatoid arthritis, fibrosis, cardiovascular disease, CKD Cachexia, Osteoarthritis Development Stage (1) In vivo tests in ...
More
Gertler Arieh
Background: Dental disorders occur when there are changes in oral hygiene, diet, medicaments or age. Our Innovation Novel dental coating that delivers therapeutics over time, as required, in response to sensed changes in acidic/basic conditions ...
More
Friedman Michael
  Background Many kinds of surfaces are notorious sources of infection. Eradication of bacteria immobilized as biofilms on these surfaces is a major biological problem. Prevention of the development of biofilms is of prime concern to ...
More
Friedman Michael
Once-daily, sustained-release Sirolimus delivery system Categories Oral Cavity, Oncology/Cancer, Sustained Release, Drug Delivery Development Stage Prototypes tested in vitro; pharmokinetic and pharmacodynamic testing in human volunteers ...
More
Friedman Michael
Background Agonists that bind well to the cannabinoid CB2 receptor and do not bind, or only bind weakly to the cannabinoid CB1 receptor are very promising therapeutic compounds for a wide range of disorders. CB1 agonists (such as the ...
More
Mechoulam Raphael
Background Metal based anti-tumor therapeutics Cisplatin and Carboplatin are two of the most widely prescribed anticancer agents. However, not all tumors can be treated with Cisplatin. In addition, Cisplatin may cause an extremely toxic ...
More
Tshuva Edit
  Background With advances in biotechnology, nasal drug delivery is increasingly becoming a more viable alternative to oral and injectable routes of administration for an increasing number of drugs, including peptides. Our Innovation Platform ...
More
Touitou Elka
 Background Quorum sensing takes place in biofilms where microbes such as bacteria and fungi are at close proximity to one another Inter species quorum sensing may affect microbes’ physiology and virulence properties, resulting in the ...
More
Steinberg Doron
   Categories Air born allergies including Asthma, hay fever, atopic dermatitis.  Development Stage In vivo and in vitro studies have been completed as well as development of the medical device Patent ...
More
Shoseyov Oded
  Background DNA mutations in mitochondrial proteins/enzymes (nuclear encoded) that may lead to disease are present in approximately 1 in 8,000 individuals. Any treatment for mitochondrial diseases must be capable of targeting and crossing the ...
More
Galski- Lorberboum Haya